Get the Stockscreener App
84.62
0.20%
-0.17
After Hours:
84.62
Prestige Consumer Healthcare Inc stock is traded at $84.62, with a volume of 283.55K.
It is down -0.20% in the last 24 hours and up +1.98% over the past month.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
See More
Previous Close:
$84.79
Open:
$84.79
24h Volume:
283.55K
Relative Volume:
0.76
Market Cap:
$4.18B
Revenue:
$1.11B
Net Income/Loss:
$205.95M
P/E Ratio:
20.59
EPS:
4.11
Net Cash Flow:
$254.64M
1W Performance:
+0.17%
1M Performance:
+1.98%
6M Performance:
-1.24%
1Y Performance:
+30.55%
1-Day Range:
$84.08
$84.98
1-Week Range:
$84.08
$86.19
52-Week Range:
$63.79
$90.04
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Name
Prestige Consumer Healthcare Inc
Sector
Phone
(914) 524-6800
Address
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
84.62 | 4.17B | 1.11B | 205.95M | 254.64M | 4.11 |
|
HLN
Haleon Plc Adr
|
11.12 | 50.98B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
168.61 | 74.41B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.93 | 4.03M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.99 | 46.23B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.25 | 20.10B | 16.54B | -1.64B | 749.00M | -1.45 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-24 | Downgrade | Sidoti | Buy → Neutral |
| Jun-21-24 | Upgrade | DA Davidson | Neutral → Buy |
| Nov-17-22 | Initiated | Canaccord Genuity | Buy |
| May-10-22 | Upgrade | Jefferies | Hold → Buy |
| May-09-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Aug-07-20 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-29-20 | Upgrade | Sidoti | Neutral → Buy |
| Apr-14-20 | Downgrade | Jefferies | Buy → Hold |
| Apr-07-20 | Resumed | Sidoti | Neutral |
| Mar-26-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-24-20 | Initiated | Oppenheimer | Perform |
| Mar-19-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-04-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jun-02-17 | Upgrade | Jefferies | Underperform → Hold |
| May-22-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-27-16 | Reiterated | B. Riley & Co. | Buy |
| Nov-17-16 | Initiated | Gabelli & Co | Buy |
| Aug-12-16 | Upgrade | Sidoti | Neutral → Buy |
| Mar-08-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Feb-05-16 | Initiated | Piper Jaffray | Overweight |
| Nov-30-15 | Downgrade | Jefferies | Hold → Underperform |
| Apr-28-14 | Reiterated | B. Riley & Co. | Buy |
| Apr-28-14 | Reiterated | Oppenheimer | Outperform |
| Jul-09-13 | Initiated | B. Riley & Co. | Buy |
View All
Prestige Consumer Healthcare Inc Stock (PBH) Latest News
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick - Yahoo Finance
Zacks Research Issues Optimistic Outlook for PBH Earnings - Defense World
Tidal Investments LLC Sells 1,380 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Equities Analysts Set Expectations for PBH Q1 Earnings - Defense World
Cetera Investment Advisers Invests $413,000 in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
The Sandlot Star Patrick Renna Teams Up with Dramamine® to Revisit an Iconic SceneThis Time, Puke Free - The Malaysian Reserve
Lice Treatment Market Deep Research Report Identifies Key TrendsPrestige Consumer Healthcare, Reckitt - openPR.com
Prestige Consumer Gains 35.7% in a Year: What's Driving the Stock? - Nasdaq
Prestige Consumer Healthcare Inc. (NYSE:PBH) Holdings Decreased by Nuveen Asset Management LLC - Defense World
Deutsche Bank AG Purchases 14,929 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Prestige Consumer Healthcare Inc. (NYSE:PBH) Position Reduced by Ameriprise Financial Inc. - Defense World
Prestige Consumer Healthcare (NYSE:PBH) Upgraded to “Buy” at StockNews.com - Defense World
Weekly Recap: 14 Health Press Releases You Need to See - Yahoo Finance
Prestige's Diversified Portfolio and Strong Execution Should Drive Steady Growth Across Categories - Morningstar
Prestige Consumer Stock Up 8% Since Q4 Earnings Beat, Margin Increase - MSN
U.S. News Announces the 2025-2026 Best OTC Medicine & Health Products - Morningstar
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q4 2025 Earnings Call Transcript - Insider Monkey
How To Trade (PBH) - news.stocktradersdaily.com
Prestige Consumer Healthcare’s Earnings Call Highlights Growth Amid Challenges - TipRanks
Aussie Stocks Hold Steady With US-China Trade Optimism - Finimize
Prestige Consumer Healthcare (NYSE:PBH) Cut to “Hold” at StockNews.com - Defense World
Prestige Consumer Healthcare Full Year 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Prestige Consumer Healthcare (NYSE:PBH) Stock Rating Upgraded by Royal Bank of Canada - Defense World
Jefferies raises Prestige Brands target to $85, maintains Hold rating By Investing.com - Investing.com India
Decoding Prestige Consumer Healthcare Inc (PBH): A Strategic SWO - GuruFocus
Saline Nasal Spray Market to See Ongoing Evolution | Major Giants Pfizer Inc,Bayer AG,Novartis AG - newstrail.com
Jefferies raises Prestige Brands target to $85, maintains Hold rating - Investing.com
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Reasonably Well - simplywall.st
Prestige Consumer Healthcare Inc. SEC 10-K Report - TradingView
Prestige Consumer Healthcare Reports Record Fiscal 2025 Results - TipRanks
Prestige Consumer Healthcare: Fiscal Q4 Earnings Snapshot - Greenwich Time
Prestige Consumer Healthcare Q4 2025 Earnings Call Transcript - MarketBeat
Transcript : Prestige Consumer Healthcare Inc., Q4 2025 Earnings Call, May 08, 2025 - marketscreener.com
Prestige: Diversified Portfolio and Strong Execution Drive Steady Growth Across Categories - Morningstar
Premium Brands Holdings (PBH) Target Price Raised by Scotiabank - GuruFocus
Prestige Consumer Healthcare (PBH) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Prestige Consumer Healthcare to Seek M&A - marketscreener.com
UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings | PBH Stock News - GuruFocus
Prestige Consumer Healthcare Inc. Q4 Profit Increases, Beats Estimates - Nasdaq
Prestige Consumer Healthcare (PBH) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance
UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings - Bluefield Daily Telegraph
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Rev - GuruFocus
Prestige Consumer (PBH) Reports Strong Q4 Revenue and Earnings Growth | PBH Stock News - GuruFocus
Prestige Consumer Healthcare Reports Record Fiscal Year Revenue - TipRanks
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings - The Manila Times
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings | PBH Stock News - GuruFocus
Earnings Flash (PBH) Prestige Consumer Healthcare Posts Q4 Revenue $296.5M, vs. FactSet Est of $291.1M - marketscreener.com
Prestige Consumer Healthcare Inc Stock (PBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.51%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):